Endocrinology CME

Stay on top of your game with the StatPearls Physician Unlimited CME programs. With 6,046 activities, StatPearls is the largest CME provider in the world. These Pub-Med Indexed articles are categorized into 162 specialty areas which lets you better access activities that will make the biggest impact on your practice. One subscription allows access to all the activities, including all state-requirements.

Pricing Options

• 6 Month subscription: All 6,339 CME Activities – $249 per 6 months
• Annual subscription: All 6,339 CME Activities – $349 per 1 year
• Lifetime: All 6,339 CME Activities + Access to Board Reviews Forever – $1999

SiMCare Diabetes is a breakthrough method for clinician education. As an interactive online learning tool using patient-case simulation, SiMCare Diabetes delivers education where and when it is needed.

SiMCare Diabetes is designed to meet the following education objectives:
• Accurately diagnose type 1 or type 2 diabetes, hypertension, dyslipidemia and obesity.
• Adjust medication to achieve individualized care goals for blood sugars, A1C, blood pressure, LDL.
• Appropriately recommend patient self-monitoring of blood glucose (SMBG) testing.
• Provide accurate referral for specialty care.
• Identify diabetes-related comorbidities such as depression and hypoglycemia unawareness.

Target Audience:
Primary care physicians, physician assistants, nurse practitioners, pharmacists, dietitians and diabetes educators.

Topics covered in Intensive Review of Endocrinology and Metabolism include:
Adrenal Dysfunction, Menopause, Thyroid Nodules and Cancer, Male Hypogonadism and Infertility, Endocrine Surgery, Obesity, Diabetes Therapeutics: From New Insulins to Incretins, Female Hypogonadism, Pituitary Disorders, Metabolic Bone Disease and many more.

Studying Intensive Review of Endocrinology and Metabolism will help you to:
• Prepare for the ABIM endocrinology board exams
• Identify and effectively manage endocrine disorders in patients of varying ages
• Apply new information to everyday endocrinology care, improving diagnostic accuracy and management decisions
• Analyze the impact of endocrine disorders on women’s health, including pregnancy
• Appraise the management of osteoporosis and suggest effective preventive measures in diabetic care

About 50 activities on various aspects of diabetes. Not all activities offer Physician CME, so be sure to check the type of CME offered before you start. The actual content is located at PRESENTdiabetes.com, but this site (Diabetes in Control) is easier to navigate.

Target Audience: Diabetes professionals

Eleven activities covering various endocrine topics; the most recent are:
• Above and Beyond Glycemic Control
• Above and Beyond Glycemic Control: Reducing the Risk of Cardiovascular Disease
Before the Breaking Point: Reducing the Risk of Osteoporotic Fracture
• Practical Lipidology: Best of Lipid Forum
• Managing the Full Spectrum of Cardiovascular Risk Factors: A Closer Look at GLP-1 Agonists
• The New Treatment Paradigm in Obesity: Proper Patient Selection, Assessment of Comorbidities, and Stepped Interventions
• Dialogues in Diabetes: Volume 2, Number 1
• Growth Hormone Deficiency and Other Causes of Short Stature: Trends in Diagnosis, Evaluation, and Treatment in Children and Adults
• GLP-1 Agonists: Examining New Data on Cardiovascular Risk Reduction, Combination Insulin Therapy, and Adherence
• Weighing in on the Beneficial Effects of GLP-1 Agonists: Assessing Cardiovascular Risk Reduction, Combination Therapy and Adherence
• Cardiovascular Risk Reduction

Target Audience: Physicians specializing in Endocrinology

Two activities at present:

Obstructive Sleep Apnea and the Cardiometabolic Syndrome: Clinical Perspectives and Interrelationships “will teach you to recognize the sometimes subtle, nonspecific symptoms and clinical presentation of obstructive sleep apnea, and why you should refer both patients with suspected OSA and patients with cardiometabolic syndrome to a sleep specialist for evaluation and intervention.”

Handling the Hand-off: Transitioning from Pediatric to Adult Diabetes Care “was developed from presentations made at the live symposium titled Handling the Hand-off: Transitioning from Pediatric to Adult Diabetes Care that took place on August 6, 2010, in San Antonio, TX, as part of the AADE’s Annual Meeting.

Target Audience: Physicians specializing in Endocrinology

CME activities of special interest to endocrinologists. Medscape contains a variety of educational formats:

CONFERENCE COVERAGE – Reports of advances presented at major medical conferences; typically includes several tracks with news stories, expert interviews, and in-depth topic overviews.

CLINICAL UPDATE – Comprehensive original review article on scientific advances in a clinical topic.

FAST TRACK CLINICAL UPDATE – Narrowly focused original review article on scientific advances in a clinical topic.

CME-LIVE – Real-time online events with streaming video, synchronized visuals, and interactive questions and answers; archived for 1 year.

CLINICAL BRIEFS – Daily reports of major current medical research articles; 0.25 credits each

JOURNAL CME – Articles selected from a wide selection of peer-reviewed journals.
SPECIAL REPORT CME – Topic-based monthly email newsletter distributed to Medscape’s professional member database by specialty.

INTERACTIVE PATIENT CASES – Original CME activity presented to the physician in an interactive, clinical case-based format. (See especially eMedicine CME Case Presentations.)
CME CIRCLE – Multimedia content certified by other accredited professional education providers, typically from live symposia or monographs, and then posted on Medscape and archived for one year.

Target Audience: Physicians specializing in Endocrinology

New perspectives in diabetes offers knowledge, competency, and practice improvements in the diagnosis, management, and treatment of patients with type 2 diabetes mellitus. The following topics are discussed:
• The Role of the Kidney in Glucose Homeostasis
• Prevention of CVD Events in Diabetes
• The Role of SGLT2 Inhibition in T2DM
• Improving Patient-Provider Communication Techniques
• The Value of Managing the ABCs: A1C, blood pressure, and Cholesterol
• When Should We Use SGLT2 Inhibitors?
• Emerging T2DM Therapies Targeting the Kidney
• Interactive Case : Patient with inadequate control of A1C levels currently on metformin
• Interactive Case : Type 2 Diabetes Mellitus with CV Risk
• Summaries of recently published articles with expert perspective on how results can be applied in clinical practice

Target Audience: Physicians focusing on Endocrinology

Activity Description / Statement of Need:

In this online, self-learning activity:

Gaucher disease (GD) is characterized by a deficiency of the lysosomal enzyme glucocerebrosidase, resulting in the accumulation of sphingolipids throughout the body but most manifesting prominently in the bones. GD is subcategorized based on clinical features: type 1 GD is the non-neuronopathic form and affects mainly the inner organs, while types 2 and 3 are the acute and sub-acute neuropathic forms, whose pathology manifests predominantly within central nervous system. GD has an estimated prevalence of 0.70 to 1.75 per 100 000 in the general population, it affects individuals of Ashkenazi Jewish heritage in significantly higher numbers. One of the first of GD’s complications is the chronic anemia and a persistent bleeding risk. Another is the hepatosplenomegaly, which may be a part of the initial clinical presentation, as may the anatomical abnormalities of bone deformities and stunted growth.

This learning activity has been designed to bring healthcare professionals’ knowledge of the strategies for treatment and management of GD up to date and to improve their competence and performance in treating it.

Target Audience:

The following healthcare professionals: Pediatricians, neurologists, endocrinologists, and primary care physicians; physician assistants and nurse practitioners in those areas of specialty; pharmacists who practice in specialty pharmacies that treat patients with rare diseases; and any other healthcare professionals with an interest in or who may clinically encounter patients with GD.

Activity Description / Statement of Need:

In this online, self-learning activity:

Non-alcoholic steatohepatitis (NASH) is a form of non-alcoholic fatty liver disease (NAFLD) characterized by steatosis, with the accumulation of fat in the liver in excess of five percent of the liver’s weight, together with hepatic inflammation in the presence or absence of fibrosis. Risk factors for NASH include a number of comorbid metabolic diseases and disorders, including metabolic syndrome, obesity, type 2 diabetes, hypertension, and dyslipidemia. The prevalence of NASH is estimated to be 1.5%-6.45% of the U.S. population, and prevalence of NASH among NAFLD patients to be 59.1% globally.

Target Audience:

The following HCPs in: Gastroenterology, hepatology, and endocrinology; physician assistants, nurse practitioners, and pharmacists who practice in the aforementioned areas of specialty; and those who otherwise have an interest in or commonly care for or clinically encounter patients with NAFLD.